Neurocrine Biosciences (NBIX)

• Market cap: $14.1B
• 1 day: -4.73%
• 5 days: -7.62%
• 1 month: -1.3%
• 3 months: -0.72%
• 6 months: 13.47%
• Year to date: 2.79%
• 1 year: 3.67%
• 5 years: 41.49%
• 10 years: 169.44%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.

Employees: 1,800